HomePress-release

Redding, California - June 19, 2024

Fill-finish Manufacturing Market to be Worth $19.14 Billion by 2031

Fill-finish Manufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Packaging Type {Vial, Syringe, Cartridge} Equipment, Service) Formulation (Oral, Parenteral) Application (Biologics, Small Molecule) End User — Global Forecast to 2031.”

Meticulous Research^®—a leading global market research company, published a research report titled “Fill-finish Manufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Packaging Type {Vial, Syringe, Cartridge} Equipment, Service) Formulation (Oral, Parenteral) Application (Biologics, Small Molecule) End User — Global Forecast to 2031.”

According to this latest publication from Meticulous Research^®, the fill-finish manufacturing market is projected to reach $19.14 billion by 2031, at a CAGR of 9.9% from 2024 to 2031.The growth of this market is driven by the growth of the biopharmaceutical industry, initiatives by pharmaceutical & biopharmaceutical companies to expand their production capacities, advancements in fill-finish manufacturing processes, and the increasing demand for pre-filled syringes. However, high operational costs and challenges in maintaining drug potency throughout the manufacturing process may restrain the market’s growth.

Moreover, initiatives aimed at increasing vaccination rates, increasing focus on biosimilar development, and rising investments in the development of new biologics are expected to create market growth opportunities. However, stringent regulatory requirements governing fill-finish manufacturing and the complexities associated with accurately filling specific medication doses are some of the challenges impeding the market’s growth.

Key Players

The key players operating in the fill-finish manufacturing market are Syntegon Technology GmbH (Germany), Becton, Dickinson and Company (U.S.), Industria Macchine Automatiche S.p.A. (Italy), West Pharmaceutical Services, Inc. (U.S.), Catalent, Inc. (U.S.), AbbVie Inc. (U.S.), Gerresheimer AG (Germany), AptarGroup, Inc. (U.S.), OPTIMA packaging group GmbH (Germany), Baxter International Inc. (U.S.), C.H. Boehringer Sohn AG & Co. KG (Germany), Schott Pharma AG & Co. KGaA (Germany), SGD Pharma (France), and Stevanato Group (Italy).

Fill-finish Manufacturing Market: Future Outlook

The fill-finish manufacturing market is segmented by Offering (Packaging Type [Product {Vials (Liquid Vials, Lyophilized Vials, and Powder Filled Vials), Syringes, Cartridges, Ampoules, and Accessories}, Material {Polymer, Glass, and Other Materials}], Packaging Instruments [System Type {Integrated Systems and Standalone Systems}, Machine Type {Automated Machines and Semi-automated Machines}, and Instrument Type {Processing Instruments and Packaging Instruments (Bottle Filling & Capping Equipment, Blow-Fill-Seal (BFS) Equipment, Aseptic Filling Equipment , Pharmaceutical Spray Filling Equipment, and Other Packaging Instruments)}], and Packaging Services [Vials & Ampoules Filling, Injection Filling, Cartridge Filling, and Other Services]), Formulation (Oral, Parenteral, Topical, and Other Formulations), Sterilization Process (Aseptic Processing and Terminal Sterilization), Application (Biologics [Type {Monoclonal Antibodies, Recombinant Hormones/Proteins, Vaccines, Cellular Based Biologics, and Gene-Based Biologics} and Development Phase {Clinical/preclinical and Commercial}] and Small Molecules [Clinical/preclinical and Commercial]), End User (Pharmaceutical & Biopharmaceutical Companies, CROs & CDMOs, and Compounding Pharmacies), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.

Among the offerings covered in this report, in 2024, the packaging type segment is expected to account for the largest share of the fill-finish manufacturing market. This segment’s large market share can be attributed to the advancements in fill-finish technology, the increasing demand for injectable and parenteral formulations, the increasing approvals of biologics, the recurring demand for syringes, cartridges, and ampoules, as well as the rising initiatives aimed at increasing vaccination rates. The rising focus on vaccination is driving the demand for vials, consequently increasing the need for fill-finish solutions that ensure contamination-free and efficient filling of vaccines into vials.

Among the formulations covered in this report, in 2024, the parenteral segment is expected to account for the largest share of the fill-finish manufacturing market. This segment’s large market share can be attributed to the rising approvals of injectables, growing preference for parenteral administration, increasing demand for parenteral packaging to ensure drug protection & purity, and technological advancements in materials and designs of pre-fillable syringes and vials.

Among the sterilization processes covered in this report, in 2024, the aseptic processing segment is expected to account for the larger share of 60.8% of the fill-finish manufacturing market. This segment’s large market share can be attributed to the rising initiatives aimed at increasing vaccination rates, the increasing demand for biologics, and the growing adoption of aseptic processing due to the need to handle heat-sensitive drugs.

Among the applications covered in this report, the biologics segment is projected to register a higher CAGR of 11.1% during the forecast period. This segment’s growth is driven by factors such as the rising adoption of Bioprocessing 4.0 technologies, government initiatives aimed at promoting biologics development, production capacity expansions by market players, and increasing approvals for biologics.

Among the end users covered in this report, in 2024, the CROs & CDMOs segment is expected to account for the largest share of the fill-finish manufacturing market. This segment’s large market share can be attributed to proliferation of CROs & CDMOs, increasing R&D funds for drug development & manufacturing, strategic partnerships between pharmaceutical companies and CROs & CDMOs, and stringent regulatory requirements governing fill-finish processes

This research report analyzes major geographies and provides a comprehensive analysis of the market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Ireland, Belgium, Denmark, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.

Among the regions covered in this report, Asia-Pacific is projected to register the highest CAGR of 11.3% during the forecast period. The growth of this regional market is driven by the growth of the pharmaceutical market, increasing investments in R&D by pharmaceutical & biopharmaceutical companies, and favorable regulatory policies. The number of new biopharmaceutical companies in China is steadily increasing. Over the past decade (2010-2020), China has witnessed the emergence of more than 140 new biotech firms, bringing the total number of active biopharmaceutical companies in the country to over 500. Additionally, the government is focusing on enhancing production capacities within the biopharmaceutical sector. Such government initiatives are contributing to the market’s growth in Asia-Pacific.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5930

Key questions answered in the report

Which are the high-growth market segments in terms of offering, formulation, sterilization process, application, end user, and region/country?
What was the historical market size for the fill-finish manufacturing market globally?
What are the market forecasts and estimates for the period 2024–2031?
What are the major drivers, restraints, challenges, opportunities, and trends in the fill-finish manufacturing market?
Who are the major players in the fill-finish manufacturing market?
What is the competitive landscape like?
What are the recent developments in the fill-finish manufacturing market?
What are the different strategies adopted by the major players in the fill-finish manufacturing market?
What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & Wastewater Technologies

Miscellaneous / Others

Redding, California - June 19, 2024

Fill-finish Manufacturing Market to be Worth $19.14 Billion by 2031

Fill-finish Manufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Packaging Type {Vial, Syringe, Cartridge} Equipment, Service) Formulation (Oral, Parenteral) Application (Biologics, Small Molecule) End User — Global Forecast to 2031.”

Recommended Readings

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies